Work

Safety and Efficacy of Menin Inhibition in Patients (Pts) with MLL-Rearranged and NPM1 Mutant Acute Leukemia: A Phase (Ph) 1, First-in-Human Study of SNDX-5613 (AUGMENT 101)

Year: 2021

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2021-146944

Authors: Eytan M. Stein, Ibrahim Aldoss, John F. DiPersio, Richard M. Stone, Martha L. Arellano, Galit Rosen, Michael L. Meyers, Yifan Huang, Steve Smith, Rebecca G. Bagley, Michael Thirman, Manish R. Patel, Ghayas C. Issa

Institutions: Memorial Sloan Kettering Cancer Center, City Of Hope National Medical Center, City of Hope, Washington University in St. Louis, Dana-Farber Cancer Institute, Emory University, Winship Cancer Institute, Syndax Pharmaceuticals (United States), University of Chicago, Oncology Specialists of Charlotte, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3213199459

Cites:

Cited by: 55

Related to: 10